- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
5. In section 24(1) (duration and renewal of licence)—
(a)in subsection (1A) after “obligation” there is inserted “(other than an obligation under the 1992 Directive)”;
(b)in subsection (3)(c) after “this Act” there is inserted “and any Community obligation under the 1965 Directive or the 1992 Directive”; and
(c)after subsection (6) there is inserted—
“(7) In this section “the 1992 Directive” means Council Directive 92/27/EEC(2) of 31st March 1992 on the labelling of medicinal products for human use and on package leaflets.”.
Section 24 was amended by regulation 4(4) of S.I. 1977/1050 and regulation 5(4) of (N.I.) S.R. 1977 No. 150, and applied by regulation 2 of, and the Schedule to, the Medicines Act 1968 (Application to Radiopharmaceutical-associated Products) Regulations 1992 See also the Medicines Act (Application to Radiopharmaceutical-associated Products) Regulations 1992 (S.I. 1992/605).
OJ No. L113,30.4.92, p.8.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include: